SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.
Toggle navigation